Published in Int J Nanomedicine on August 03, 2011
Novel magnetic fibrin hydrogel scaffolds containing thrombin and growth factors conjugated iron oxide nanoparticles for tissue engineering. Int J Nanomedicine (2012) 0.92
In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles. Chem Soc Rev (2015) 0.92
The role of neurotrophic factors conjugated to iron oxide nanoparticles in peripheral nerve regeneration: in vitro studies. Biomed Res Int (2014) 0.89
TRAIL conjugated to nanoparticles exhibits increased anti-tumor activities in glioma cells and glioma stem cells in vitro and in vivo. Neuro Oncol (2012) 0.88
Convection-enhanced delivery for the treatment of glioblastoma. Neuro Oncol (2015) 0.85
Engineering of near IR fluorescent albumin nanoparticles for in vivo detection of colon cancer. J Nanobiotechnology (2012) 0.80
Design of near-infrared fluorescent bioactive conjugated functional iron oxide nanoparticles for optical detection of colon cancer. Int J Nanomedicine (2012) 0.79
Convection-enhanced drug delivery for gliomas. Surg Neurol Int (2015) 0.78
Bench-to-bedside translation of magnetic nanoparticles. Nanomedicine (Lond) (2014) 0.77
Bioactive magnetic near Infra-Red fluorescent core-shell iron oxide/human serum albumin nanoparticles for controlled release of growth factors for augmentation of human mesenchymal stem cell growth and differentiation. J Nanobiotechnology (2015) 0.76
Age-dependent effects of microglial inhibition in vivo on Alzheimer's disease neuropathology using bioactive-conjugated iron oxide nanoparticles. J Nanobiotechnology (2013) 0.75
Antibody-conjugated, dual-modal, near-infrared fluorescent iron oxide nanoparticles for antiamyloidgenic activity and specific detection of amyloid-β fibrils. Int J Nanomedicine (2013) 0.75
Convection-Enhanced Delivery. Neurotherapeutics (2017) 0.75
Targeted Magnetic Nanoparticles for Mechanical Lysis of Tumor Cells by Low-Amplitude Alternating Magnetic Field. Materials (Basel) (2016) 0.75
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci U S A (1994) 6.61
Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res (2008) 5.67
Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy. Int J Nanomedicine (2008) 2.20
High-flow microinfusion: tissue penetration and pharmacodynamics. Am J Physiol (1994) 2.01
Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time. J Neurosurg (1999) 1.97
Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion. J Neurosurg (1995) 1.94
Methotrexate-immobilized poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery. Small (2006) 1.88
Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia. Int J Hyperthermia (1993) 1.77
Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood (2004) 1.76
Biochemical and clinical aspects of methotrexate neurotoxicity. Chemotherapy (2003) 1.71
Convection-enhanced delivery of nanocarriers for the treatment of brain tumors. Biomaterials (2009) 1.59
Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase. Biochim Biophys Acta (2002) 1.56
Getting into the brain: approaches to enhance brain drug delivery. CNS Drugs (2009) 1.47
Convection-enhanced drug delivery: increased efficacy and magnetic resonance image monitoring. Cancer Res (2005) 1.35
Intraparenchymal drug delivery via positive-pressure infusion: experimental and modeling studies of poroelasticity in brain phantom gels. IEEE Trans Biomed Eng (2002) 1.21
Phase I clinical evaluation of citrate-coated monocrystalline very small superparamagnetic iron oxide particles as a new contrast medium for magnetic resonance imaging. Invest Radiol (2004) 1.18
Convection-enhanced delivery of maghemite nanoparticles: Increased efficacy and MRI monitoring. Neuro Oncol (2008) 1.14
Clearance of brain edema and macromolecules through the cortical extracellular space. J Neurosurg (1992) 1.10
In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells. Clin Cancer Res (2003) 1.01
Future of convection-enhanced delivery in the treatment of brain tumors. Future Oncol (2010) 0.95
Lipid drug conjugate (LDC) nanoparticles as autolymphotrophs for oral delivery of methotrexate. J Biomed Nanotechnol (2011) 0.84
Conjugating Methotrexate to magnetite (Fe(3)O(4)) nanoparticles via trichloro-s-triazine. J Mater Chem (2009) 0.83
Efficacy of thrombolytic therapy in pulmonary embolism determined by MION-enhanced MRA: an experimental study in rabbits. Invest Radiol (1998) 0.80
Microspheres for biomedical applications: preparation of reactive and labelled microspheres. Biomaterials (1993) 0.78
Polyacrolein microspheres as a new solid phase for radioimmunoassay. J Immunoassay (1986) 0.77
A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol (2003) 4.17
NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. Eur J Cancer (2012) 3.66
Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation (2007) 2.99
Altered adenosine-to-inosine RNA editing in human cancer. Genome Res (2007) 2.38
Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial. Lancet Oncol (2013) 2.08
Magnetic resonance imaging and computed tomography for the detection and characterization of nonmetallic intraocular foreign bodies. Retina (2015) 2.02
Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group. J Clin Oncol (2007) 2.01
Conflicting pathology reports: a diagnostic dilemma. J Neurosurg (2014) 1.98
MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells. Biochem Biophys Res Commun (2008) 1.85
Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study. J Neurosurg (2004) 1.78
Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma. Neuro Oncol (2010) 1.78
Ex vivo activated human macrophages improve healing, remodeling, and function of the infarcted heart. Circulation (2006) 1.77
Cerebral blood flow velocity and periventricular white matter hyperintensities in type 2 diabetes. Diabetes Care (2006) 1.52
Neurosurgery and pregnancy. Acta Neurochir (Wien) (2011) 1.52
Multimodal treatment of hemorrhagic pituitary metastasis as first manifestation of renal cell carcinoma. World Neurosurg (2012) 1.50
Epidemiology of gliomas in Israel: a nationwide study. Neuroepidemiology (2008) 1.47
The expression of three genes in primary non-small cell lung cancer is associated with metastatic spread to the brain. Clin Cancer Res (2009) 1.39
High-b-value diffusion-weighted MR imaging for pretreatment prediction and early monitoring of tumor response to therapy in mice. Radiology (2004) 1.36
Convection-enhanced drug delivery: increased efficacy and magnetic resonance image monitoring. Cancer Res (2005) 1.35
Pretreatment prediction of brain tumors' response to radiation therapy using high b-value diffusion-weighted MRI. Neoplasia (2004) 1.32
Size-selective organization of enthalpic compatibilized nanocrystals in ternary block copolymer/particle mixtures. J Am Chem Soc (2003) 1.30
Floral scents induce recall of navigational and visual memories in honeybees. J Exp Biol (2004) 1.21
Magnetic resonance imaging-guided, high-intensity focused ultrasound for brain tumor therapy. Neurosurgery (2006) 1.18
Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions. Analyst (2005) 1.15
Convection-enhanced delivery of maghemite nanoparticles: Increased efficacy and MRI monitoring. Neuro Oncol (2008) 1.14
Ammonium trichloro(dioxoethylene-o,o')tellurate (AS101) sensitizes tumors to chemotherapy by inhibiting the tumor interleukin 10 autocrine loop. Cancer Res (2004) 1.11
Quantitative MRI measurements of human fetal brain development in utero. Neuroimage (2006) 1.11
S 17092: a prolyl endopeptidase inhibitor as a potential therapeutic drug for memory impairment. Preclinical and clinical studies. CNS Drug Rev (2002) 1.08
Enhancement of incisional wound healing by thrombin conjugated iron oxide nanoparticles. Biomaterials (2009) 1.07
Modeling embryogenesis and cancer: an approach based on an equilibrium between the autostabilization of stochastic gene expression and the interdependence of cells for proliferation. Prog Biophys Mol Biol (2005) 1.06
Anterograde and retrograde amnesia in a person with bilateral fornix lesions following removal of a colloid cyst. Neuropsychologia (2006) 1.03
Treatment of intra-cranial aneurysms with the SILK flow diverter: 2 years' experience with 28 patients at a single center. Acta Neurochir (Wien) (2012) 0.98
Magnetic resonance imaging-guided focused ultrasound for thermal ablation in the brain: a feasibility study in a swine model. Neurosurgery (2007) 0.96
Transsphenoidal surgery for Cushing's disease: endocrinological follow-up monitoring of 82 patients. Neurosurgery (2002) 0.96
Quantification of water compartmentation in cell suspensions by diffusion-weighted and T(2)-weighted MRI. Magn Reson Imaging (2007) 0.95
Novel magnetic fibrin hydrogel scaffolds containing thrombin and growth factors conjugated iron oxide nanoparticles for tissue engineering. Int J Nanomedicine (2012) 0.92
Response assessment of NovoTTF-100A versus best physician's choice chemotherapy in recurrent glioblastoma. Cancer Med (2014) 0.91
Intraoperative mapping and monitoring of the corticospinal tracts with neurophysiological assessment and 3-dimensional ultrasonography-based navigation. Clinical article. J Neurosurg (2010) 0.90
Synthesis, fluorescence and biodistribution of a bone-targeted near-infrared conjugate. Eur J Med Chem (2011) 0.90
Immunogenicity of bioactive magnetic nanoparticles: natural and acquired antibodies. J Biomed Mater Res A (2008) 0.90
Enhancement of the growth and differentiation of nasal olfactory mucosa cells by the conjugation of growth factors to functional nanoparticles. Bioconjug Chem (2011) 0.90
Synthesis of fluorescent-maghemite nanoparticles as multimodal imaging agents for amyloid-beta fibrils detection and removal by a magnetic field. Biochem Biophys Res Commun (2009) 0.89
Non-resectable slow-growing meningiomas treated by hydroxyurea. J Neurooncol (2004) 0.89
Control of magnetophoretic mobility by susceptibility-modified solutions as evaluated by cell tracking velocimetry and continuous magnetic sorting. Anal Chem (2004) 0.89
Effect of polymer-graft modification on the order formation in particle assembly structures. Langmuir (2013) 0.88
TRAIL conjugated to nanoparticles exhibits increased anti-tumor activities in glioma cells and glioma stem cells in vitro and in vivo. Neuro Oncol (2012) 0.88
Stereotactic targeting of the ventrointermediate nucleus of the thalamus by direct visualization with high-field MRI. Stereotact Funct Neurosurg (2006) 0.88
MRI study on reversible and irreversible electroporation induced blood brain barrier disruption. PLoS One (2012) 0.87
Magnetic scaffolds enriched with bioactive nanoparticles for tissue engineering. Adv Healthc Mater (2012) 0.87
First multimodal embolization particles visible on x-ray/computed tomography and magnetic resonance imaging. Invest Radiol (2011) 0.87
Radiopaque iodinated copolymeric nanoparticles for X-ray imaging applications. Biomaterials (2009) 0.87
Synthesis and characterization of uniform radiopaque polystyrene microspheres for X-ray imaging by a single-step swelling process. J Biomed Mater Res A (2006) 0.86
A rapid assay for drug sensitivity of glioblastoma stem cells. Biochem Biophys Res Commun (2007) 0.86
The application of MRI for depiction of subtle blood brain barrier disruption in stroke. Int J Biol Sci (2010) 0.86
Failed awake craniotomy: a retrospective analysis in 424 patients undergoing craniotomy for brain tumor. J Neurosurg (2012) 0.85
Management and outcome of non-traumatic cerebellar haemorrhage. Cerebrovasc Dis (2002) 0.85
Hemodynamic response imaging: a potential tool for the assessment of angiogenesis in brain tumors. PLoS One (2012) 0.85
Venous embolization during sternotomy in children undergoing corrective heart surgery. J Thorac Cardiovasc Surg (2004) 0.85
Effect of maghemite nanoparticles on insulin amyloid fibril formation: selective labeling, kinetics, and fibril removal by a magnetic field. J Biomed Mater Res A (2009) 0.84
Angiogenic factors in the cerebrospinal fluid of patients with astrocytic brain tumors. Neurosurgery (2004) 0.84
Prediction of neurological deficits and recovery after surgery in the supplementary motor area: a prospective study in 26 patients. J Neurosurg (2010) 0.84
Polystyrene microspheres as a specific marker for the diagnosis of aspiration in hamsters. Am J Respir Cell Mol Biol (2002) 0.83
Synthesis and characterization of recombinant factor VIIa-conjugated magnetic iron oxide nanoparticles for hemophilia treatment. J Biomed Mater Res A (2009) 0.83
Salirasib (farnesyl thiosalicylic acid) for brain tumor treatment: a convection-enhanced drug delivery study in rats. Mol Cancer Ther (2008) 0.83
Synthesis and characterization of magnetic and non-magnetic core-shell polyepoxide micrometer-sized particles of narrow size distribution. J Colloid Interface Sci (2008) 0.83
Clinical trial simulation in drug development. Therapie (2004) 0.82
Gastroretentive Accordion Pill: Enhancement of riboflavin bioavailability in humans. J Control Release (2006) 0.82
Gliomas of the posterior fossa in adults. J Neurooncol (2013) 0.82
The impact of enrollment in clinical trials on survival of patients with glioblastoma. J Clin Neurosci (2012) 0.82
Split immunity: immune inhibition of rat gliomas by subcutaneous exposure to unmodified live tumor cells. J Immunol (2011) 0.82
The ventricular system and choroid plexus as a primary site for renal cell carcinoma metastasis. Acta Neurochir (Wien) (2014) 0.82
Supratentorial calcified pseudotumour: experience of a single institution and review of the literature. Acta Neurochir (Wien) (2014) 0.81
Language related reorganization in adult brain with slow growing glioma: fMRI prospective case-study. Neurocase (2008) 0.81
Radiopaque iodinated polymeric nanoparticles for X-ray imaging applications. Biomaterials (2007) 0.81
Engineering of near infrared fluorescent proteinoid-poly(L-lactic acid) particles for in vivo colon cancer detection. J Nanobiotechnology (2014) 0.81